NCT05364411View on ClinicalTrials.gov

HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons in HNSCC

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2026

Conditions
Head and Neck Squamous Cell CarcinomaHypofractionationRadiotherapyProton TherapyImmune System Suppression
Interventions
RADIATION

HYpofractionated, Dose-redistributed RAdiotherapy (HYDRA)

20 daily fractions, 5 times per week

RADIATION

conventional fractionated radiotherapy

35 daily fractions, 5 times per week

Trial Locations (1)

3015 GL

RECRUITING

Erasmus MC, Rotterdam

Sponsors

Collaborators (1)

Erasmus Medical Center
All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

HollandPTC

INDUSTRY

lead

Joris B.W. Elbers

OTHER

NCT05364411 - HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons in HNSCC | Biotech Hunter | Biotech Hunter